Table 3.
6 mo OS | 9 mo OS | 12 mo OS | ||
---|---|---|---|---|
Study | Treatment | All Pts (%) | All Pts (%) | All Pts (%) |
ERC 1671 | ERC 1671 | 100 | 80 | 40 |
Taal (BELOB) | BEV Monotherapy |
62 | 45 | 26 |
Field (CABARET) | 61 | 39 | 24 | |
Heiland (Freiburg, Germany) | 18 | 12 | 10 |
6 mo OS | 9 mo OS | 12 mo OS | ||
---|---|---|---|---|
Study | Treatment | All Pts (%) | All Pts (%) | All Pts (%) |
ERC 1671 | ERC 1671 | 100 | 80 | 40 |
Taal (BELOB) | BEV Monotherapy |
62 | 45 | 26 |
Field (CABARET) | 61 | 39 | 24 | |
Heiland (Freiburg, Germany) | 18 | 12 | 10 |